Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts

Executive Summary

CEO Ian Read says selling the consumer business has to do more than boost Pfizer's treasury. "If there is a better mix, we are always open to it, but it has to be for strategic reasons rather than cash," he says.


Related Content

Pfizer Keeps Hands On Consumer Product Wheel In Opting Against Split
The Fall Of Pfizergan: The Beginning, The End And Everything In Between
Light Still On For Switches After Pfizer Pulls Plug On OTC Lipitor


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts